TY - JOUR
T1 - Decreased bone mineral density in rats rendered follicle-deplete by an ovotoxic chemical correlates with changes in follicle-stimulating hormone and inhibin A
AU - Lukefahr, A. L.
AU - Frye, J. B.
AU - Wright, L. E.
AU - Marion, S. L.
AU - Hoyer, P. B.
AU - Funk, J. L.
N1 - Funding Information:
We thank Seymour Reichlin for his insightful contributions to the preparation of this article. This work was supported by grant R21AT003614 (to J. L. F.) from the National Center for Complementary and Alternative Medicine (NCCAM) and the Office of Dietary Supplements (ODS), with partial support by grant ES09246 (to P. B. H.) from the National Institute for Environmental Health Sciences (NIEHS). All work herein is solely the responsibility of the authors and does not necessarily reflect the views of NCCAM, ODS, NIEHS, or the National Institutes of Health.
PY - 2012/3
Y1 - 2012/3
N2 - Bone loss during perimenopause, an estrogen-sufficient period, correlates with elevated serum follicle-stimulating hormone (FSH) and decreased inhibins A and B. Utilizing a recently described ovotoxin-induced animal model of perimenopause characterized by a prolonged estrogen-replete period of elevated FSH, we examined longitudinal changes in bone mineral density (BMD) and their association with FSH. Additionally, serum inhibin levels were assessed to determine whether elevated FSH occurred secondary to decreased ovarian inhibin production and, if so, whether inhibins also correlated with BMD. BMD of the distal femur was assessed using dual-energy X-ray absorptiometry (DXA) over 19 months in Sprague-Dawley rats treated at 1 month with vehicle or 4-vinylcyclohexene diepoxide (VCD, 80 or 160 mg/kg daily). Serum FSH, inhibins A and B, and 17-ß estradiol (E2) were assayed and estrus cyclicity was assessed. VCD caused dose-dependent increases in FSH that exceeded values occurring with natural senescence, hastening the onset and prolonging the duration of persistent estrus, an acyclic but E2-replete period. VCD decreased serum inhibins A and B, which were inversely correlated with FSH (r2 = 0.30 and 0.12, respectively). In VCD rats, significant decreases in BMD (5-13%) occurred during periods of increased FSH and decreased inhibins, while BMD was unchanged in controls. In skeletally mature rats, FSH (r = 0.13) and inhibin A (r =0.15) correlated with BMD, while inhibin B and E2 did not. Thus, for the first time, both the hormonal milieu of perimenopause and the association of dynamic perimenopausal changes in FSH and inhibin A with decreased BMD have been reproduced in an animal model.
AB - Bone loss during perimenopause, an estrogen-sufficient period, correlates with elevated serum follicle-stimulating hormone (FSH) and decreased inhibins A and B. Utilizing a recently described ovotoxin-induced animal model of perimenopause characterized by a prolonged estrogen-replete period of elevated FSH, we examined longitudinal changes in bone mineral density (BMD) and their association with FSH. Additionally, serum inhibin levels were assessed to determine whether elevated FSH occurred secondary to decreased ovarian inhibin production and, if so, whether inhibins also correlated with BMD. BMD of the distal femur was assessed using dual-energy X-ray absorptiometry (DXA) over 19 months in Sprague-Dawley rats treated at 1 month with vehicle or 4-vinylcyclohexene diepoxide (VCD, 80 or 160 mg/kg daily). Serum FSH, inhibins A and B, and 17-ß estradiol (E2) were assayed and estrus cyclicity was assessed. VCD caused dose-dependent increases in FSH that exceeded values occurring with natural senescence, hastening the onset and prolonging the duration of persistent estrus, an acyclic but E2-replete period. VCD decreased serum inhibins A and B, which were inversely correlated with FSH (r2 = 0.30 and 0.12, respectively). In VCD rats, significant decreases in BMD (5-13%) occurred during periods of increased FSH and decreased inhibins, while BMD was unchanged in controls. In skeletally mature rats, FSH (r = 0.13) and inhibin A (r =0.15) correlated with BMD, while inhibin B and E2 did not. Thus, for the first time, both the hormonal milieu of perimenopause and the association of dynamic perimenopausal changes in FSH and inhibin A with decreased BMD have been reproduced in an animal model.
KW - 4-Vinylcyclohexene diepoxide
KW - Bone
KW - Estradiol
KW - Follicle-stimulating hormone
KW - Inhibin
KW - Osteoporosis
KW - Perimenopause
UR - http://www.scopus.com/inward/record.url?scp=84868324985&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84868324985&partnerID=8YFLogxK
U2 - 10.1007/s00223-011-9565-2
DO - 10.1007/s00223-011-9565-2
M3 - Article
C2 - 22249524
AN - SCOPUS:84868324985
SN - 0171-967X
VL - 90
SP - 239
EP - 249
JO - Calcified Tissue International
JF - Calcified Tissue International
IS - 3
ER -